Keeping tabs on infectious disease

A look at our new online venue for infectious diseases as well as upcoming coverage
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00

Well, we pretty much started this year with a pandemic (though for many of us it wasn’t until March that we felt the full impact of that), and we’re finishing the year that way as well. Rampant public optimism early on that we would be out of the woods by summer clearly didn’t pan out, and many of us will be remaining virtual shut-ins for the winter, it seems.

As you have no doubt noticed in these pages, we continue to keep our fingers on the pulse of COVID-19 R&D, and we are doing the same in the Infectious Disease e-newsletter that many of you may also be getting, which has branched out from its original coronavirus-only focus but is still mainly covering COVID. In addition, DDN, along with its sister publications at LabX Media, takes part in the Infectious Disease Network Facebook page at http://www.facebook.com/InfectiousDiseaseNetwork.

Pathogens remain a major threat (and sometimes just a nuisance) across many areas, and we promise we won’t let SARS-CoV-2 be the only one on which we turn the spotlight. In fact, the December/January issue will have a Special Report on infectious disease—and also a story about a virtual fireside chat on antibiotics—followed by a Focus Feature in the February issue on Vaccines.

Stay healthy and keep with us as we follow these important R&D areas.

About the Author

Related Topics

Published In

Volume 16 - Issue 10 | November 2020

November 2020

November 2020 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue